Cargando…
A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience
BACKGROUND: Although culture-based methods remain a staple element of microbiology analysis, advanced molecular methods increasingly supplement the testing repertoire. Since the advent of 16s and 18s ribosomal RNA PCR in the 2000s, there has been interest in its utility for pathogen detection. Nonet...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509882/ https://www.ncbi.nlm.nih.gov/pubmed/34637486 http://dx.doi.org/10.1371/journal.pone.0258552 |
_version_ | 1784582451927973888 |
---|---|
author | Teoh, TeeKeat McNamara, Rachel Powell, James O’Connell, Nuala H. Dunne, Colum P. |
author_facet | Teoh, TeeKeat McNamara, Rachel Powell, James O’Connell, Nuala H. Dunne, Colum P. |
author_sort | Teoh, TeeKeat |
collection | PubMed |
description | BACKGROUND: Although culture-based methods remain a staple element of microbiology analysis, advanced molecular methods increasingly supplement the testing repertoire. Since the advent of 16s and 18s ribosomal RNA PCR in the 2000s, there has been interest in its utility for pathogen detection. Nonetheless, studies assessing the impact on antimicrobial prescribing are limited. We report a single-centre experience of the influence of 16s and 18s PCR testing on antimicrobial treatment, including a cost-analysis. METHODS: Data were collected retrospectively for all samples sent for 16s and 18s PCR testing between January 2014 and December 2020. Results were compared to any culture-based result. Assessment focused on any change of antimicrobial treatment based on PCR result, or use of the result as supportive evidence for microbiological diagnosis. RESULTS: 310 samples relevant to 268 patients were referred for 16s/18s rRNA PCR testing during the period. Culture was performed for 234 samples. Enrichment culture was performed for 83 samples. 82 of 300 samples sent for 16s PCR had positive results (20.8%). When culture was performed, enrichment reduced the outcome of 16s PCR only positive results (4/36 [11.1%] versus 14/35 [40.0%], p = 0.030 where a pathogen found). 18s PCR yielded 9 positive results from 67 samples. The 16s PCR result influenced antimicrobial change for 6 patients (2.2%). We estimated the cost for 16s PCR testing to result in one significant change in antimicrobial therapy to be €3,340. 18s PCR did not alter antimicrobial treatment. CONCLUSION: There was limited impact of 16s PCR results on antimicrobial treatments. Relevance to practice was affected by relatively long turn-around-time for results. Utility may be increased in specialised surgical centres, or by reducing turn-around-time. Enrichment culture should be considered on samples where 16s PCR is requested. There remains limited evidence for use of 18s PCR in clinical management, and further studies in this area are likely warranted. |
format | Online Article Text |
id | pubmed-8509882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-85098822021-10-13 A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience Teoh, TeeKeat McNamara, Rachel Powell, James O’Connell, Nuala H. Dunne, Colum P. PLoS One Research Article BACKGROUND: Although culture-based methods remain a staple element of microbiology analysis, advanced molecular methods increasingly supplement the testing repertoire. Since the advent of 16s and 18s ribosomal RNA PCR in the 2000s, there has been interest in its utility for pathogen detection. Nonetheless, studies assessing the impact on antimicrobial prescribing are limited. We report a single-centre experience of the influence of 16s and 18s PCR testing on antimicrobial treatment, including a cost-analysis. METHODS: Data were collected retrospectively for all samples sent for 16s and 18s PCR testing between January 2014 and December 2020. Results were compared to any culture-based result. Assessment focused on any change of antimicrobial treatment based on PCR result, or use of the result as supportive evidence for microbiological diagnosis. RESULTS: 310 samples relevant to 268 patients were referred for 16s/18s rRNA PCR testing during the period. Culture was performed for 234 samples. Enrichment culture was performed for 83 samples. 82 of 300 samples sent for 16s PCR had positive results (20.8%). When culture was performed, enrichment reduced the outcome of 16s PCR only positive results (4/36 [11.1%] versus 14/35 [40.0%], p = 0.030 where a pathogen found). 18s PCR yielded 9 positive results from 67 samples. The 16s PCR result influenced antimicrobial change for 6 patients (2.2%). We estimated the cost for 16s PCR testing to result in one significant change in antimicrobial therapy to be €3,340. 18s PCR did not alter antimicrobial treatment. CONCLUSION: There was limited impact of 16s PCR results on antimicrobial treatments. Relevance to practice was affected by relatively long turn-around-time for results. Utility may be increased in specialised surgical centres, or by reducing turn-around-time. Enrichment culture should be considered on samples where 16s PCR is requested. There remains limited evidence for use of 18s PCR in clinical management, and further studies in this area are likely warranted. Public Library of Science 2021-10-12 /pmc/articles/PMC8509882/ /pubmed/34637486 http://dx.doi.org/10.1371/journal.pone.0258552 Text en © 2021 Teoh et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Teoh, TeeKeat McNamara, Rachel Powell, James O’Connell, Nuala H. Dunne, Colum P. A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience |
title | A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience |
title_full | A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience |
title_fullStr | A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience |
title_full_unstemmed | A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience |
title_short | A retrospective observational study of the impact of 16s and 18s ribosomal RNA PCR on antimicrobial treatment over seven years: A tertiary hospital experience |
title_sort | retrospective observational study of the impact of 16s and 18s ribosomal rna pcr on antimicrobial treatment over seven years: a tertiary hospital experience |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509882/ https://www.ncbi.nlm.nih.gov/pubmed/34637486 http://dx.doi.org/10.1371/journal.pone.0258552 |
work_keys_str_mv | AT teohteekeat aretrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT mcnamararachel aretrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT powelljames aretrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT oconnellnualah aretrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT dunnecolump aretrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT teohteekeat retrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT mcnamararachel retrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT powelljames retrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT oconnellnualah retrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience AT dunnecolump retrospectiveobservationalstudyoftheimpactof16sand18sribosomalrnapcronantimicrobialtreatmentoversevenyearsatertiaryhospitalexperience |